Cunningham D - Search Results

1

Inactivation of NF1 Promotes Resistance to EGFR Inhibition in KRAS/NRAS/BRAF^V600 -Wild-Type Colorectal Cancer.

Georgiou A, Stewart A, Cunningham D, Banerji U, Whittaker SR. Georgiou A, et al. Among authors: cunningham d. Mol Cancer Res. 2020 Jun;18(6):835-846. doi: 10.1158/1541-7786.MCR-19-1201. Epub 2020 Feb 25. Mol Cancer Res. 2020. PMID: 32098826 Free PMC article.

2

Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides.

Ross PJ, George M, Cunningham D, DiStefano F, Andreyev HJ, Workman P, Clarke PA. Ross PJ, et al. Among authors: cunningham d. Mol Cancer Ther. 2001 Nov;1(1):29-41. Mol Cancer Ther. 2001. PMID: 12467236

3

Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling.

Clarke PA, George ML, Easdale S, Cunningham D, Swift RI, Hill ME, Tait DM, Workman P. Clarke PA, et al. Among authors: cunningham d. Cancer Res. 2003 Oct 15;63(20):6855-63. Cancer Res. 2003. PMID: 14583483

4

The role of cetuximab in the therapy of previously treated advanced colorectal cancer.

Chong G, Cunningham D. Chong G, et al. Among authors: cunningham d. Semin Oncol. 2005 Dec;32(6 Suppl 9):S55-8. doi: 10.1053/j.seminoncol.2005.04.020. Semin Oncol. 2005. PMID: 16399433 Review.

5

Treatment in advanced colorectal cancer: what, when and how?

Chau I, Cunningham D. Chau I, et al. Among authors: cunningham d. Br J Cancer. 2009 Jun 2;100(11):1704-19. doi: 10.1038/sj.bjc.6605061. Epub 2009 May 12. Br J Cancer. 2009. PMID: 19436303 Free PMC article. Review.

6

Colorectal cancer.

Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B, Starling N. Cunningham D, et al. Lancet. 2010 Mar 20;375(9719):1030-47. doi: 10.1016/S0140-6736(10)60353-4. Lancet. 2010. PMID: 20304247 Review.

7

Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancer.

Asghar U, Hawkes E, Cunningham D. Asghar U, et al. Among authors: cunningham d. Clin Colorectal Cancer. 2010 Dec;9(5):274-81. doi: 10.3816/CCC.2010.n.040. Clin Colorectal Cancer. 2010. PMID: 21208841 Review.

8

Targeting the PI3K-AKT-mTOR signaling network in cancer.

Khan KH, Yap TA, Yan L, Cunningham D. Khan KH, et al. Among authors: cunningham d. Chin J Cancer. 2013 May;32(5):253-65. doi: 10.5732/cjc.013.10057. Chin J Cancer. 2013. PMID: 23642907 Free PMC article. Review.

9

Phase I trials in patients with relapsed, advanced upper gastrointestinal carcinomas: experience in a specialist unit.

Khan K, Ang JE, Starling N, Sclafani F, Shah K, Judson I, Molife LR, Banerji U, de Bono JS, Cunningham D, Kaye SB. Khan K, et al. Among authors: cunningham d. Gastric Cancer. 2014 Oct;17(4):621-629. doi: 10.1007/s10120-013-0328-9. Epub 2014 Jan 21. Gastric Cancer. 2014. PMID: 24445485 Free PMC article. Clinical Trial.

10

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.

Sclafani F, Chau I, Cunningham D, Peckitt C, Lampis A, Hahne JC, Braconi C, Tabernero J, Glimelius B, Cervantes A, Begum R, Gonzalez De Castro D, Hulkki Wilson S, Eltahir Z, Wotherspoon A, Tait D, Brown G, Oates J, Valeri N. Sclafani F, et al. Among authors: cunningham d. Ann Oncol. 2015 Sep;26(9):1936-1941. doi: 10.1093/annonc/mdv285. Epub 2015 Jul 10. Ann Oncol. 2015. PMID: 26162609 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,232 results

Search Page

Filters